Faropenem Medoxomil is a daloxate ester prodrug form of faropenem, a penem with a tetrahydrofuran substituent at position C2, with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes. Faropenem medoxomil is hydrolyzed in vivo to release the active free acid. Compared with imipenem, faropenem has improved chemical stability and reduced central nervous system effects. Additionally, faropenem is resistant to hydrolysis by many beta-lactamases. It is grouped under the following drug class(es): Beta-lactams and Carbapenems. Its therapeutic use is listed as antibiotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Faropenem daloxate and Orapem. Its PubChem CID is 6918218.
Faropenem medoxomil
| CAS No | 141702-36-5 |
|---|---|
| Molecular Formula | C17H19NO8S |
| Molecular Weight | 397.40 g/mol |
| Synonyms | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Faropenem Medoxomil is a daloxate ester prodrug form of faropenem, a penem with a tetrahydrofuran substituent at position C2, with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes.
The listed CAS number is 141702-36-5.
The listed molecular formula is C17H19NO8S.
The listed molecular weight is 397.40 g/mol.
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate.
The source lists Faropenem daloxate and Orapem.